Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
NK Wolf, DU Kissiov, DH Raulet - Nature Reviews Immunology, 2023 - nature.com
Great strides have been made in recent years towards understanding the roles of natural
killer (NK) cells in immunity to tumours and viruses. NK cells are cytotoxic innate lymphoid …
killer (NK) cells in immunity to tumours and viruses. NK cells are cytotoxic innate lymphoid …
Natural killer cells: development, maturation, and clinical utilization
AM Abel, C Yang, MS Thakar… - Frontiers in …, 2018 - frontiersin.org
Natural killer (NK) cells are the predominant innate lymphocyte subsets that mediate anti-
tumor and anti-viral responses, and therefore possess promising clinical utilization. NK cells …
tumor and anti-viral responses, and therefore possess promising clinical utilization. NK cells …
A vaccine targeting resistant tumours by dual T cell plus NK cell attack
Most cancer vaccines target peptide antigens, necessitating personalization owing to the
vast inter-individual diversity in major histocompatibility complex (MHC) molecules that …
vast inter-individual diversity in major histocompatibility complex (MHC) molecules that …
The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy
S Paul, G Lal - Frontiers in immunology, 2017 - frontiersin.org
Natural killer (NK) cells are innate immune cells that show strong cytolytic function against
physiologically stressed cells such as tumor cells and virus-infected cells. NK cells show a …
physiologically stressed cells such as tumor cells and virus-infected cells. NK cells show a …
NKG2D receptor and its ligands in host defense
LL Lanier - Cancer immunology research, 2015 - AACR
NKG2D is an activating receptor expressed on the surface of natural killer (NK) cells, CD8+
T cells, and subsets of CD4+ T cells, invariant NKT cells (iNKT), and γδ T cells. In humans …
T cells, and subsets of CD4+ T cells, invariant NKT cells (iNKT), and γδ T cells. In humans …
Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma
Background & Aims No adjuvant therapy has been shown to extend the survival of patients
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …
[HTML][HTML] STAT3 gain-of-function mutations connect leukemia with autoimmune disease by pathological NKG2Dhi CD8+ T cell dysregulation and accumulation
The association between cancer and autoimmune disease is unexplained, exemplified by T
cell large granular lymphocytic leukemia (T-LGL) where gain-of-function (GOF) somatic …
cell large granular lymphocytic leukemia (T-LGL) where gain-of-function (GOF) somatic …
NK cells mediate clearance of CD8+ T cell–resistant tumors in response to STING agonists
CJ Nicolai, N Wolf, IC Chang, G Kirn, A Marcus… - Science …, 2020 - science.org
Several immunotherapy approaches that mobilize CD8+ T cell responses stimulate tumor
rejection, and some, such as checkpoint blockade, have been approved for several cancer …
rejection, and some, such as checkpoint blockade, have been approved for several cancer …
Targeting natural killer cells and natural killer T cells in cancer
Natural killer (NK) cells and natural killer T (NKT) cells are subsets of lymphocytes that share
some phenotypical and functional similarities. Both cell types can rapidly respond to the …
some phenotypical and functional similarities. Both cell types can rapidly respond to the …
Regulation of ligands for the NKG2D activating receptor
NKG2D is an activating receptor expressed by all NK cells and subsets of T cells. It serves
as a major recognition receptor for detection and elimination of transformed and infected …
as a major recognition receptor for detection and elimination of transformed and infected …